⏳ Fetching live dividend data...
Home › Calculator › LIXTW Dividend Calculator 2026
Lixte Biotechnology Holdings, Inc. · NASDAQ
Price: $0.02 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in LIXTW → $411247769057630720.00M in 10 years · $33,896,095,565,470,776,000,000.00/month
Lixte Biotechnology Holdings, Inc. functions as a biopharmaceutical firm dedicated to the discovery and development of innovative therapeutic compounds. The company leverages advanced biomarker technology to create novel drug candidates aimed at combating severe and widespread human diseases. Its core research primarily concentrates on protein phosphatase inhibitors, which are being explored for standalone administration or in conjunction with cytotoxic agents, radiation therapy, and immune checkpoint blockers. The company's developmental pipeline includes two distinct series of pharmacologically active agents, both progressing through various preclinical and clinical phases. The LB-100 series comprises new chemical entities designed to address cancers, vascular ailments, and metabolic disorders. Meanwhile, the LB-200 series is being developed to treat chronic hereditary conditions, such as Gaucher's disease, alongside certain types of cancer and neurodegenerative illnesses. Lixte Biotechnology Holdings, Inc. maintains significant research collaborations, including a clinical trial agreement with the Moffitt Cancer Center and Research Institute Hospital Inc. It also has partnership agreements for investigator-initiated clinical trials with the Spanish Sarcoma Group, as well as the Netherlands Cancer Institute and Oncode Institute. Established in 2005, the company's headquarters are located in Pasadena, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open LIXTW position with:
Real after-tax yield depends on where you live and how you hold LIXTW.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 9049.77% | 9046.97% | $904,977 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 7692.30% | 7689.50% | $769,230 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 7239.82% | 7237.02% | $723,982 / yr |
| 🇬🇧 UK ISA | 0% | 9049.77% | 9046.97% | $904,977 / yr |
| 🇬🇧 UK Taxable | 8.75% | 8257.92% | 8255.12% | $825,792 / yr |
| 🇨🇦 TFSA | 0% | 9049.77% | 9046.97% | $904,977 / yr |
| 🇨🇦 CA Taxable | 25% | 6787.33% | 6784.53% | $678,733 / yr |
| 🇦🇺 Super (pension) | 15% | 7692.30% | 7689.50% | $769,230 / yr |
| 🇦🇺 AU Taxable | 30% | 6334.84% | 6332.04% | $633,484 / yr |
| 🇩🇪 DE Taxable | 26.375% | 6662.89% | 6660.09% | $666,289 / yr |
| 🇫🇷 FR Taxable | 30% | 6334.84% | 6332.04% | $633,484 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
LIXTW pays quarterly — 4 times per year. Next ex-div: TBD.
How LIXTW compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LIXTW sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LIXTW dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Lixte Biotechnology Holdings, Inc. (LIXTW) is currently trading at $0.02, 98% below its 52-week high. The current dividend yield is 9049.77% based on an annual payout of $2.00 per share.
Lixte Biotechnology Holdings, Inc. (LIXTW) is a healthcare stock currently trading at $0.02 with a dividend yield of 9049.77%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever